Anticoagulants – Oral

SDCEP Management of dental patients taking

anticoagulants or antiplatelet drugs

The Scottish Dental Clinical Effectiveness Programme (SDCEP) provides guidance on the management of dental patients taking anticoagulants or antiplatelet drugs. These medications, commonly prescribed for the prevention of thromboembolic events, can significantly affect dental treatment plans, particularly those involving surgical procedures that could lead to bleeding.

Oral anticoagulants, like warfarin or direct oral anticoagulants (DOACs), and antiplatelet drugs such as aspirin and clopidogrel, inhibit blood clotting mechanisms to varying degrees. Therefore, managing patients on these medications requires careful consideration to balance the risk of bleeding against the risk of thrombosis.

Key considerations from the SDCEP guidance for patients on oral anticoagulants include:

1. **Patient Assessment:** Review the patient’s medication regimen, including drug name, dosage, and the indication for anticoagulant therapy.

2. **Consultation with Prescribing Healthcare Professional:** Obtain information regarding the patient’s latest blood test results, such as the International Normalized Ratio (INR) for warfarin users, and confer about the need for any medication adjustments before dental procedures.

3. **Minimize Bleeding Risk:** Employ local measures to reduce the risk of bleeding, such as using local hemostatic agents, suturing, and advising on postoperative care.

4. **Procedure Planning:** For minor oral surgery, it may be unnecessary to alter anticoagulant medication if adequate local hemostatic measures are in place. For major oral surgery, more significant alterations in the anticoagulant regimen may be required under the guidance of the patient’s healthcare provider.

5. **Patient Education:** Instruct patients on signs of postoperative bleeding and provide clear guidance on what to do if they experience any issues.

6. **Follow-up:** Arrange for appropriate patient monitoring and follow-up after dental procedures to assess healing and manage any complications.

The SDCEP guidance is an aid to clinicians to make informed decisions and provide safe and effective dental care for patients who are at an increased risk of bleeding due to their anticoagulant or antiplatelet therapy. Following such guidelines helps to minimize complications and ensures coordinated care between dental providers and the patient’s broader healthcare team.

For the most current guidance and detailed recommendations, dental professionals should refer to the latest version of the SDCEP guidelines or consult with a patient’s medical doctor when making treatment decisions.

Published March 2022 (2nd Edition)

Quick references; guides and information in this area can be found below.

Management of Dental Patients

Taking Anticoagulants or Antiplatelet Drugs

Anticoagulants-Quick-Reference-Guide

Note:  If you find any of the links above are broken, please report it to us via the Contact page.